Global Intussusception Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, and Others.

By Treatment Type;

Surgical, Non-Surgical, and Medication.

By Diagnostic Method;

Ultrasound, CT Scan, and X-Ray.

By Application;

Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn150591533 Published Date: April, 2025 Updated Date: May, 2025

Introduction

Global Intussusception Market (USD Million), 2021 - 2031

In the year 2024, the Global Intussusception Market was valued at USD 6,577.20 million. The size of this market is expected to increase to USD 8,890.88 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.


Global Intussusception Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 4.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.4 %
Market Size (2024)USD 6,577.20 Million
Market Size (2031)USD 8,890.88 Million
Market ConcentrationHigh
Report Pages315
6,577.20
2024
8,890.88
2031

Major Players

  • AbbVie Inc.
  • AMAG Pharmaceuticals (Covis Pharma)
  • Daiichi Sankyo Company, Ltd.
  • Sanofi
  • Vifor Pharma Management Ltd. (CSL)
  • PHARMACOSMOS A/S
  • Zydus Group

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Intussusception Market

Fragmented - Highly competitive market without dominant players


The global intussusception market is seeing remarkable expansion due to heightened awareness and significant advancements in diagnostic and treatment techniques for this urgent medical condition. Intussusception, where part of the intestine telescopes into another section, primarily affects young children. The increasing rate of diagnoses, coupled with the availability of effective treatments, has spurred growth in the market for medical interventions and therapeutic solutions.

Advancements in Early Detection and Treatment
With early detection critical for optimal outcomes, about 20% of intussusception cases in children require surgical intervention. However, non-invasive treatments such as ultrasound-guided reduction are now being widely adopted, driving a shift towards more effective, minimally invasive options. This advancement has resulted in a significant reduction in the need for surgery and improved patient recovery rates.

Technological Breakthroughs Shaping Treatment Options
Technological progress in minimally invasive procedures and non-surgical reduction techniques is transforming how intussusception is treated. These innovations have significantly improved treatment success rates, with over 75% of cases now treated successfully without the need for surgery. Additionally, enhanced imaging technologies and the integration of robotic assistance in surgery are making procedures faster and more accurate.

Rising Public Awareness and Enhanced Healthcare Systems
As public awareness of pediatric health issues grows, more parents and caregivers are seeking immediate medical attention, contributing to market expansion. The continuous improvement in healthcare infrastructure, along with better education for healthcare professionals on diagnosing and managing pediatric emergencies, is expected to drive a 5–8% compound annual growth rate (CAGR) in the market over the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Treatment Type
    3. Market Snapshot, By Diagnostic Method
    4. Market Snapshot, By Application
    5. Market Snapshot, By Region
  4. Global Intussusception Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Pediatric Population Increase

        2. Advanced Diagnostic Technologies

        3. Surgical Advancements

      2. Restraints
        1. Treatment Complexity

        2. Limited Awareness

        3. Healthcare Accessibility

      3. Opportunities
        1. Early Intervention Strategies

        2. Minimally Invasive Procedures

        3. Emerging Markets Expansion

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Intussusception Market, By Product, 2021 - 2031 (USD Million)
      1. Iron Dextran

      2. Iron Sucrose

      3. Ferric Carboxymaltose

      4. Others

    2. Global Intussusception Market, By Treatment Type, 2021 - 2031 (USD Million)

      1. Surgical

      2. Non-Surgical

      3. Medication

    3. Global Intussusception Market, By Diagnostic Method, 2021 - 2031 (USD Million)

      1. Ultrasound

      2. CT Scan

      3. X-Ray

    4. Global Intussusception Market, By Application, 2021 - 2031 (USD Million)
      1. Chronic Kidney Disease

      2. Inflammatory Bowel Disease

      3. Cancer

      4. Others

    5. Global Intussusception Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. AbbVie Inc.
      2. AMAG Pharmaceuticals (Covis Pharma)
      3. Daiichi Sankyo Company, Ltd.
      4. Sanofi
      5. Vifor Pharma Management Ltd. (CSL)
      6. PHARMACOSMOS A/S
      7. Zydus Group
  7. Analyst Views
  8. Future Outlook of the Market